ArticleThrombosis research2011

Engineered virus-like nanoparticles reverse heparin anticoagulation more consistently than protamine in plasma from heparin-treated patients.

Andrew J Gale et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.